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Certain Saccharomyces cerevisiae strains produce killer toxins
which kill sensitive cells. This phenomenon is important for strains
to survive in natural and industrial populations. Toxins are able to kill
the nonkiller and different type killer yeast belonging to the same or
other genera while the producing cells remain immune to the action
of its own or relative toxins. Depending on the differences of toxins'
molecular features, killer effects and encoding genetic determinants
there are three types of killer systems: K1, K2, and K28. Among those,
the mechanism of action of K2 killer is the least understood. In order
to describe the mechanism of K2 action it is necessary to analyse not
only the intraspecial activity but also its effect on other microorgan-
isms. It is known that some yeast killer strains have antibacterial
activity but the performed microbiological tests are not sensitive
enough to determine it. Instrumental studies carried out with
susceptible yeasts and bacteria are more sensitive.
The objective of our work was the evaluation of K2 killer toxins'
impact on different microorganisms applying microbiological methods
and performing bioluminescence and electrochemical analysis to
characterise the energetical state of cells. It was shown that during the
action K2 toxin decreases the level of ATP and the gradients of small
molecules. Our study demonstrated that measurements of biolumi-
nescence and electrochemical analysis are very useful methods for
determination of the sensitivity of cells to toxin and the analysis of
killing mechanisms.
doi:10.1016/j.bbabio.2012.06.416
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Dystrophin is a subsarcolemmal protein critical for the integrity of
muscle ﬁbers by linking the actin cytoskeleton to the extracellular
matrix via the dystroglycan complex (DGC). DGC also occurs at
dermal–epidermal junction in skin. Here we report for the ﬁrst time
that epidermal melanocytes express dystrophin. The full-length
muscle isoform of dystrophin (mDp427) was clearly detectable in
skin sections as assessed by RNA analysis. Dystrophin was selectively
expressed at the basal layer of melanocytes where it co-localized with
basement membrane (BM) components. Dystrophin was absent in
the epidermis of Duchenne muscular dystrophy (DMD patients),
while dystroglycans and BM components were normally expressed.
We have characterized mitochondrial function in primary cultures
of melanocytes from one normal donor and two DMD patients.
Mitochondria readily accumulated tetramethylrhodamine methyl
ester, indicating that they are energized irrespective of the presence
of dystrophin. On the other hand, and at variance from mitochondria
of control donors, mitochondria of DMD patients readily depolarized
upon the addition of oligomycin, suggesting either that they are
maintaining the membrane potential at the expense of glycolytic ATP,
or that they are affected by a latent dysfunction unmasked by inhibition
of the ATP synthase. We are currently investigating the basis for
this anomalous response to oligomycin, which in Ullrich congenital
muscular dystrophy is caused by sensitization of the permeability
transition pore. Since melanocyte cultures can be easily obtained by
conventional skin biopsies, they represent a promising cellular model
for studying and monitoring dystrophinopathies and their response to
experimental treatments.
doi:10.1016/j.bbabio.2012.06.417
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Mitochondrial DNA (mtDNA) variations including single nucleo-
tide polymorphisms (SNPs) have been proposed to be involved in
idiosyncratic drug reactions. However, current in vitro and in vivo
models lack the genetic diversity seen in the human population. Our
hypothesis is that different cell strains with distinct mtDNA SNPs may
have different mitochondrial bioenergetic proﬁles and may therefore
vary in their response to drug-induced toxicity. Therefore, we used
an in vitro system composed of four strains of mouse embryonic
ﬁbroblasts (MEFs) with mtDNA polymorphisms. We sequenced
mtDNA from embryonic ﬁbroblasts isolated from four mouse strains,
C57BL/6J, MOLF/EiJ, CZECHII/EiJ and PERA/EiJ, with the latter two
being sequenced for the ﬁrst time. The bioenergetic proﬁle of the four
strains of MEFs was investigated at both passage 3 and 10. Our results
showed that there were clear differences among the four strains of
MEFs at both passages, with CZECHII/EiJ having a lower mitochon-
drial robustness when compared to C57BL/6J, followed by MOLF/EiJ
and PERA/EiJ. Seven drugs known to impair mitochondrial function
were tested for their effect on the ATP content of the four strains of
MEFs in both glucose- and galactose-containing media. Our results
showed that there were strain-dependent differences in the response
to some of the drugs. We propose that this model is a useful starting
point to study compounds that may cause mitochondrial off-target
toxicity in early stages of drug development, thus decreasing the
number of experimental animals used.
doi:10.1016/j.bbabio.2012.06.418
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Spinal and bulbar muscular atrophy (SBMA) is a motor neuron
disease caused by polyglutamine expansionmutation in the androgen
receptor (AR). Since skeletal muscle mitochondrial dysfunction was
observed in neuromuscular disorders and may play a role in disease
progression, we assessed the effect of mutant AR on the transcription
of mitochondrial proteins in muscle tissue of ten SBMA patients and
of age–gender matched controls. We found a similar expression of AR
in SBMA muscle tissues compare the controls. On the contrary,
immunohistochemistry and western blot analysis revealed a signif-
icant 4-fold increase of AR protein level in the nuclei of SBMA patients
(pb0.01).
When compared with healthy control subjects, patients with
SBMA had similar levels of mRNA and protein of PGC-1a, TFAM,
MnSod as well as a similar amount of mRNA of PGC-1b, ERRa, NRF1,
mitofusin 1 and mitofusin2. Taken together these results show that in
human SBMA skeletal muscle, mutant AR did not affect expression
and presence of mitochondrial proteins. Notably we found a 48%
reduction in mtDNA copy number (pb0.03), compare to controls and
to muscle of eight patients with amyotrophic lateral sclerosis (ALS),
suggesting a speciﬁc involvement of mutant AR in the mtDNA
homeostasis.
doi:10.1016/j.bbabio.2012.06.419
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Apoptosis or programmed cell death is essential for embryonic
development as well as cellular homeostasis and many other
mechanisms in multicellular organisms. Although many studies have
elucidated several molecular mechanisms of the regulation of
apoptosis and the role of Bax and Bak involved, the detailed mech-
anism remains not fully understood. As Bak is localized at the mito-
chondrial outer membrane it requires continuous regulation to
prevent uncontrolled apoptosis. This is controlled, in part, due to its
associationwith the porin VDAC2. Studies into themode of interaction
between Bak and VDAC2 and aspects to the mechanism of regulation
will be presented.
doi:10.1016/j.bbabio.2012.06.420
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Mitochondria possess their own double-stranded DNA which is
replicated by an assembly of nuclear encoded proteins including
polymerase gamma (POLG) as the sole replicase, also involved in
mtDNA repair [1].
Pathogenic mutations in POLG are known to be associated with
different neurodegenerative disorders, e.g. Alpers–Huttenlocher
syndrome and CPEO [2,3]. Until now the impact of POLG mutations
on the biochemical phenotype remains enigmatic.
MtDNA copy numbers were determined in ﬁbroblasts of two POLG
patients exhibiting mild to severe clinical phenotypes. The ﬁrst
patient (p1), carrying heterozygous mutations in the linker domain
(p.Arg627Trp; p.Trp748Ser) showed a mild clinical phenotype
whereas the second patient (p2), harboring a homozygous mutation
in the polymerase domain (Arg1096Cys), showed a severe phenotype
(multifocal therapy-refractory epilepsy, reduced mtDNA copy num-
ber and multiple deletions in muscle). Both patients exhibited a slight
but not signiﬁcant decrease in their mtDNA content in ﬁbroblasts.
Measurements of respiration rates (ADP-stimulated) revealed no
signiﬁcant differences in any of the two cell lines compared to
controls.
To examine these ﬁndings in detail, ﬁbroblasts of p2 and a control
line were depleted of mtDNA by long-term treatment with 20 μM
ddC, followed by a repopulation phase. In both phases oxygen
consumption and mtDNA content were measured. During depletion
mtDNA content and respiration rates were signiﬁcantly diminished in
both lines. In contrast to controls, in POLG ﬁbroblasts both mtDNA
copy number and respiration rates remained low during a 65 day
repopulation phase.
Our results strongly indicate that the respiration rates correlate
directly with the mtDNA copy number.
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The hydrolysis of inorganic pyrophosphate (PPi), an ubiquitous
energy-rich metabolite, is required for most anabolic reactions to
proceed. This essential reaction (EC 3.6.1.1) is catalyzed by two major
classes of non-homologous proteins globally named pyrophosphatases
(PPases): the widely-distributed soluble PPases (sPPases) that simply
hydrolyse PPi, and the ion-pumping membrane PPases, H+(or Na+)-
PPases, that couple PPi-hydrolysis to the generation of transmem-
brane electrochemical gradients. sPPases are located in fungal and
animal cells cytosol, and in energy-converting organelles (mitochon-
dria, chloroplasts), but are absent in cytosol of photosynthetic plant
cells, where membrane PPases do work instead of them. These PPases
conform to the simplest class of primary ion pumps known to date,
allowing PPi usage as a “low-cost” energy currency alternative to ATP
[1].
We optimized the heterologous expression of diverse membrane
PPases in yeast by manipulating their N-terminal domains with
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